November 11, 2013

Rheonix to Showcase Automated Molecular Diagnostics Technology at Association for Molecular Pathology Annual Meeting

ITHACA, N.Y. – Rheonix Inc., a developer of fully automated molecular testing solutions, will address the need for access to critical advanced molecular testing, labor shortages that limit the availability of testing, and other obstacles laboratories face in adoption of this technology at the Association for Molecular Pathology (AMP) 2013 Annual Meeting in Phoenix, Ariz., Nov. 14-16. Rheonix will display its Chemical and Reagent Device (CARD) and EncompassMDx™ molecular testing platform.… Read More »